Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pharmacogenetics and Pharmacogenomics: Overview01:29

Pharmacogenetics and Pharmacogenomics: Overview

Pharmacogenetics and pharmacogenomics examine how genetic factors influence an individual's response to drugs. While pharmacogenetics focuses on the impact of specific genetic variants on drug effects, pharmacogenomics takes a broader approach, studying how genetic variation across populations contributes to differences in drug responses. These fields aim to explain why individuals may experience varying levels of efficacy or adverse reactions to the same medication.Variability in drug...
Pharmacogenetics of Drug Metabolism: Overview01:27

Pharmacogenetics of Drug Metabolism: Overview

Genetic polymorphism in drug metabolism is crucial to the inter-individual variability observed in drug responses. Drug metabolism primarily involves the chemical modification of drugs and other xenobiotics to enhance their elimination by increasing their polarity. Two main classes of enzymes mediate this biotransformation process: Phase I enzymes, primarily cytochrome P450s, catalyze oxidation and reduction reactions, while other enzymes, such as esterases, mediate hydrolysis, and Phase II...
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu01:29

Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu

Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
Principles of Pharmacogenetics: Types of Genetic Variants01:27

Principles of Pharmacogenetics: Types of Genetic Variants

The human genome is over 99.9% identical between individuals, yet genetic differences exist at millions of bases. The human genome contains approximately 3 million variant positions per individual, many of which are heterozygous, contributing to genetic diversity and individual traits. Genetic variations include single-nucleotide polymorphisms (SNPs), insertions, deletions, and copy number variations (CNVs).SNPs, the most common variation, involve single-base changes in DNA. These can be...
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
Pharmacogenetics of Phase I Enzymes: Cytochrome P450 Isozymes01:28

Pharmacogenetics of Phase I Enzymes: Cytochrome P450 Isozymes

Cytochrome P450 (CYP450) enzymes are a superfamily of heme-containing monooxygenases that play a pivotal role in Phase I drug metabolism by catalyzing oxidation and reduction reactions.These enzymes transform lipophilic xenobiotics into more hydrophilic metabolites, facilitating subsequent Phase II conjugation and eventual excretion. The CYP450 family is classified into families (e.g., CYP1–CYP3) and subfamilies (e.g., CYP2A, CYP2C), based on amino acid sequence homology.CYP450 isoenzymes,...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Commentary on Hoffmann E, Malolepszy L, Hochscheid C, Dettmeyer R, Fritzenwanker M. Stillbirth with a false-positive lung float test result - an unusual case report.

Forensic science, medicine, and pathology·2026
Same author

Partial cannabis legalization and the increase of the THC threshold in road traffic: a statistical analysis of traffic cases before and after legal changes.

Traffic injury prevention·2026
Same author

Commentary on: Byard RW. A forensic overview of deaths in mountainous terrain.

Forensic science, medicine, and pathology·2025
Same author

The mystery of the "air-dried chaplain" solved: the life and "afterlife" of an unusual human mummy from eighteenth century Austria.

Frontiers in medicine·2025
Same author

Postmortem mutilation in a case of natural death.

Forensic science, medicine, and pathology·2025
Same author

Sudden unexpected death due to B-cell acute lymphocytic leukaemia (B-ALL) in a 3-year-old child.

Forensic science, medicine, and pathology·2025

Related Experiment Video

Updated: Jun 9, 2026

Enhanced Genetic Analysis of Single Human Bioparticles Recovered by Simplified Micromanipulation from Forensic ‘Touch DNA’ Evidence
11:49

Enhanced Genetic Analysis of Single Human Bioparticles Recovered by Simplified Micromanipulation from Forensic ‘Touch DNA’ Evidence

Published on: March 9, 2015

Pharmacogenetics and forensic toxicology.

Frank Musshoff1, Ulrike M Stamer, Burkhard Madea

  • 1Institute of Forensic Medicine, Stiftsplatz 12, 53111 Bonn, Germany. f.musshoff@uni-bonn.de

Forensic Science International
|September 11, 2010
PubMed
Summary

Genetic, physiological, and environmental factors cause significant variability in how individuals respond to drugs. Understanding pharmacogenetics is crucial for personalized medicine and forensic toxicology.

More Related Videos

High-throughput and Comprehensive Drug Surveillance Using Multisegment Injection-Capillary Electrophoresis-Mass Spectrometry
10:17

High-throughput and Comprehensive Drug Surveillance Using Multisegment Injection-Capillary Electrophoresis-Mass Spectrometry

Published on: April 23, 2019

Related Experiment Videos

Last Updated: Jun 9, 2026

Enhanced Genetic Analysis of Single Human Bioparticles Recovered by Simplified Micromanipulation from Forensic ‘Touch DNA’ Evidence
11:49

Enhanced Genetic Analysis of Single Human Bioparticles Recovered by Simplified Micromanipulation from Forensic ‘Touch DNA’ Evidence

Published on: March 9, 2015

High-throughput and Comprehensive Drug Surveillance Using Multisegment Injection-Capillary Electrophoresis-Mass Spectrometry
10:17

High-throughput and Comprehensive Drug Surveillance Using Multisegment Injection-Capillary Electrophoresis-Mass Spectrometry

Published on: April 23, 2019

Area of Science:

  • Pharmacogenetics and Toxicogenetics
  • Forensic Toxicology
  • Drug Metabolism and Transport

Background:

  • Individual responses to medications vary widely due to genetic, physiological, and environmental factors.
  • These variations influence drug absorption, distribution, metabolism, and target interactions.
  • Key genetic elements include drug metabolizing enzymes (e.g., cytochrome P450), transporters, and target genes.

Purpose of the Study:

  • To review the relevance of pharmacogenetics and toxicogenetics in forensic toxicology.
  • To highlight how genetic differences impact drug response and concentration.
  • To provide practical examples from routine forensic toxicology cases.

Main Methods:

  • Review of scientific literature on pharmacogenetics, toxicogenetics, and forensic toxicology.
  • Analysis of genetic variations affecting drug-metabolizing enzymes, transporters, and targets.
  • Case study examples illustrating the application of pharmacogenetic principles.

Main Results:

  • Genetic polymorphisms significantly alter pharmacokinetic (drug concentration) and pharmacodynamic (drug effect) profiles.
  • Variations in cytochrome P450 enzymes and drug transporters are major contributors to inter-individual differences.
  • Pharmacogenetic testing can aid in interpreting drug concentrations and toxicity in forensic investigations.

Conclusions:

  • Pharmacogenetics and toxicogenetics are essential for understanding drug variability in forensic contexts.
  • Genetic factors play a critical role in drug response, toxicity, and metabolism.
  • Integrating pharmacogenetic insights improves the accuracy and relevance of forensic toxicology findings.